ASX Announcements
December 2024
Sonic Healthcare to buy German lab group for $700m
Pathology giant Sonic Healthcare is buying one of Germany’s top medical lab groups as it seeks to expand its market share in Europe.
- Michael Smith
June 2024
Sonic Healthcare-backed Harrison.ai boots up $100m-plus Series C raise
Harrison.ai’s management team has commenced discussions with a handful of potential investors regarding the cash call.
- Sarah Thompson, Kanika Sood and Emma Rapaport
- Opinion
- Chanticleer
What Australia’s great contrarian is buying – and avoiding
Soaring household debt will have ripple effects for ASX investors, according to Schroders’ head of Australian equity, Martin Conlon.
- Updated
- James Thomson
Crescent Capital set to take radiology business off The Growth Fund
Crescent Capital, which claims to be the country’s most active private equity manager in healthcare, has secured exclusivity.
- Sarah Thompson, Kanika Sood and Emma Rapaport
May 2024
- Opinion
- Pathology
This routine health test is an investment opportunity
The share prices of pathology companies are below pre-pandemic levels and the world will need more blood tests.
- Mark Draper
December 2023
- Opinion
- Retail
Health, the new frontier for Wesfarmers, Woolworths
Wesfarmers and Woolworths are uniquely positioned to disrupt the health sector by building ecosystems in partnership with insurers and care providers, says Jarden.
- Sue Mitchell
September 2023
What Djokovic taught this fund manager about investing
Daniel Moore aims to be the GOAT of funds management. He’s buying Sonic Healthcare, avoiding iron ore and says the market has missed a trick on a little-known REIT.
- Joshua Peach
July 2023
- Opinion
- Chanticleer
Pathology dream deal a three-headed competition nightmare
Forget the terms of Australian Clinical Labs’ offer for Healius. What is important is what the regulator says about combining the No.2 and No.3 pathology groups.
- Updated
- Anthony Macdonald
June 2023
Why this fundie is betting on more M&A action by Sonic Healthcare
Infinity’s Piers Bolger explains why he’s staying away from consumer stocks such as Baby Bunting and City Chic.
- Joanne Tran
May 2023
- Opinion
- Ageing
Ways to invest in the Baby Boomer megatrend
With the population over 65 expected to grow at twice the rate of the Australian population, likely winners include healthcare companies and financial services.
- Mark Draper
April 2023
Pathology brawl heats up as rivals argue finer points
The trickiest M&A deals are often when two industry players are eyeing each other off, but cannot agree on the terms. That’s what’s going on between the No.2 and No.3 players in the pathology sector.
- Anthony Macdonald
February 2023
Sonic Healthcare shares soar as profit beats pre-pandemic levels
The diagnostic’s company profit was down 54 per cent, but well above pre-pandemic levels, pushing shares to a three-month-high.
- Tess Bennett
December 2022
- Analysis
- Executive shake-up
New Healius CEO needs to win back investor trust
The pathology giant is also poised to name a new head of its Lumus Imaging who will start in January.
- Carrie LaFrenz
- Exclusive
- Executive shake-up
Healius CEO poised to step down next year
After five tough years at the helm of the pathology and imaging player, Dr Malcolm Parmenter plans to retire next year.
- Updated
- Carrie LaFrenz
November 2022
Microba shares soar 55pc after Sonic Healthcare investment
The diagnostics giant has acquired a 19.99 per cent stake in the small-cap biotech and is also seeking approval for another 5 per cent.
- Yolanda Redrup
August 2022
COVID will mean more testing for longer: Sonic chief
The healthcare company is on the lookout for deals all the time, says chief executive Colin Goldschmidt.
- Updated
- Jemima Whyte
July 2022
Buy, hold, sell: Five stocks battling for blue chip status
Two fund managers take a look at the stocks climbing their way up the index into the ASX 20.
- Opinion
- Sharemarket
How to pick the right healthcare investments
Longer life expectancy together with the ageing of the global population presents investors with mouth-watering opportunities, but there are plenty of traps.
- Mark Draper
June 2022
How Sonic Healthcare and a local AI start-up will shake up pathology
Sonic and Harrison.ai have teamed up to launch Franklin.ai, aiming to speed up the diagnosis and detection of cancer, and other tissue-based diseases.
- Yolanda Redrup
March 2022
Barrenjoey, Macquarie equity strategists give their budget verdict
Strategists have revealed which corners of the sharemarket will benefit most from the fresh wave of stimulus announced in the federal budget.
- Updated
- Alex Gluyas